An observational study in Infertility, Aneuploidy and Chromosome Abnormality, sponsored by Assisting Nature. Status unknown at 1 site in Greece. Open to female participants aged 18 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-28.
Sponsored by Assisting Nature · Observational
This is a prospective randomised study of the evaluation of the clinical IVF results after time lapse assisted embryo selection versus Non-invasive PGT-A assisted embryo selection in subfertile women.
A randomized prospective study focusing on subfertile women undergoing IVF treatment followed by embryo transfer on the blastocyst stage.
Women assigned to group A proceed to embryo transfer, after time lapse assisted embryo selection, while women of group B after non-invasive PGT-A assisted embryo selection.
IVF outcomes, regarding the success rate of the trasnfer and the time required to achieve conception is studied in both groups.
2,085 studies on the registry are indexed under Infertility; 357 are open to participants now.
This study's planned enrollment of 200 is close to the median of 200 across 592 observational studies indexed under Infertility.
Browse Infertility studies →Assisting Nature is the lead sponsor of 11 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Women aged 18- 39, faced with infertility issues, meeting the above inclusion criteria.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Women who proceed to embryo transfer after time lapse assisted embryo selection.
Other: embryo selection
Women who proceed to embryo transfer after non-invasive PGT-A assisted embryo selection.
Other: embryo selection
The basis of embryo seletion for transfer: morphological or genetic after non-invasive PGT-A
Embryotransfers to conceive
The number of the embryotransfers required for women to conceive
Time frame: Up to the embryotransfer of the last enrolled patient (Dec 2023)
Time interval to conceive
Time interval required for women to conceive (in months): from OPU day to positive hCG test
Time frame: Up to the pregnancy test after the last embryo transfer of an enrolled patient (Jan 2024)
Cumulative Live Birth Rate
Cumulative Live Birth Rate achieved after one OPU treatment
Time frame: Up to 38 weeks after the embryo transfer
Abortion rate
The spontaneous miscarriage of women in both groups
Time frame: Up to 2nd trimester miscarriages
DaC rate
The rate of the dilation and curretage rate in both groups
Time frame: Up to 24 weeks of pregnancy according to Greek Law
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Oct 2022; primary completion for Dec 2023, 14 months later.
Of 209 non-industry observational studies under Infertility, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 100. This study's planned 14 months is below that.
Counting every sponsor, half of 242 studies reached it within 39 months; a quarter within 16 and three quarters within 100.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assisting Nature